Placental protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration
| Autor: | Hamutal Meiri, Tijana Drobnjak, George Osol, Sveinbjörn Gizurarson, Berthold Huppertz, Anna Margrét Jónsdóttir, Helga Helgadóttir, Marei Sammar, Maurizio Mandalà, Margrét Soffía Runólfsdóttir |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
medicine.medical_treatment Prostaglandin Vasodilation Preeclampsia 03 medical and health sciences chemistry.chemical_compound 0302 clinical medicine Internal medicine Placenta Maternity and Midwifery medicine 030212 general & internal medicine Saline Pregnancy 030219 obstetrics & reproductive medicine business.industry Obstetrics and Gynecology medicine.disease 3. Good health Endocrinology medicine.anatomical_structure Blood pressure Oncology End of day chemistry business |
| Zdroj: | International Journal of Women's Health. 11:213-222 |
| ISSN: | 1179-1411 |
| Popis: | Introduction Reduced concentrations of placental protein 13 (PP13) during the first trimester of human pregnancy are associated with elevated risk for the subsequent development of preeclampsia, which is one of the deadliest obstetrical complications of pregnancy. Previous studies by our group have shown that PP13 lowers blood pressure in pregnant rats, increases the size and weight of pups and placentas, and induces vasodilation of resistance arteries through endothelial signaling pathways involving endothelial nitric oxid synthase and prostaglandin. Methods In the present study, the effect of PP13 was investigated in nonpregnant female Sprague Dawley rats (n=27). Osmotic pumps were surgically implanted subcutaneously that released a constant dose of PP13 or saline over 7 days. Most animals were sacrificed 6 days after the end of PP13 release (on day 13), while some were sacrificed immediately at the end of day 7 (the last PP13 release day), to compare the short- and long-term impact of PP13 on vessels' growth and size. Results The uterine vessels were significantly expanded in the group exposed to recombinant PP13 (rPP13) compared to the control (saline) group. Both veins and arteries were significantly expanded by rPP13 with a more pronounced effect after 13 days compared to the corresponding vessels after 7 days. Furthermore, the long-term effect of treatment by rPP13 was more pronounced in the veins compared to the corresponding arteries. The effect of a PP13 variant with a histidine-tag (His-PP13) remained the same between 7 and 13 days. Conclusion In conclusion, PP13 might play a key role in the expansive remodeling of the uterine vessels, reflecting what would happen if the rat was pregnant, preparing the uterine vascu-lature for the increase in uteroplacental blood flow, which is necessary for normal pregnancy. We suggest that PP13 could act by NO signaling pathways, a hypothesis that requires future study. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
| Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |